Glubrava
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glubrava, covering 2022-10-18 to 2022-10-18. Get the full timeline:
Most recent: EMA Withdrawn: Glubrava (metformin hydrochloride;pioglitazone hydrochloride) — Takeda Pharma A/S